期刊论文详细信息
Frontiers in Neurology
Case report: COVID-19-associated refractory thrombotic thrombocytopenic purpura complicated with Guillain-Barré syndrome
Neurology
Shenjian Chen1  Wei Huang1  Zhiyong Sheng1  Rui Zhou1  Xinyue Zhang2  Fang Li2  Qinghua Luo3 
[1] Department of Neurological Intensive Care Unit, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China;Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China;Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China;The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China;
关键词: COVID-19;    Guillain-Barré syndrome;    thrombotic thrombocytopenic purpura;    ADAMTS-13;    rituximab;   
DOI  :  10.3389/fneur.2023.1199889
 received in 2023-04-05, accepted in 2023-05-02,  发布年份 2023
来源: Frontiers
PDF
【 摘 要 】

Thrombotic thrombocytopenic purpura (TTP), a rare and lethal thrombotic microangiopathy, is an autoimmune disease that can be triggered by viral infections such as COVID-19. This condition is characterized by hemolytic microangiopathy, thrombocytopenia, and neurologic alterations, possibly accompanied by fever and renal damage. Moreover, more than 220 patients with Guillain-Barré syndrome (GBS) have been reported in association with the COVID-19 infection. In this report, we present a case of a patient who developed refractory TTP complicated by GBS following a SARS-CoV-2 infection. We aimed to highlight the importance of accurately diagnosing neurological complications associated with a COVID-19 infection and to demonstrate our strategies for treating a patient with COVID-19 infection-related refractory TTP complicated by GBS.

【 授权许可】

Unknown   
Copyright © 2023 Zhou, Chen, Luo, Zhang, Li, Huang and Sheng.

【 预 览 】
附件列表
Files Size Format View
RO202310101785303ZK.pdf 1369KB PDF download
  文献评价指标  
  下载次数:22次 浏览次数:0次